Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51. An Uncontrolled Phase 3 Follow-up Study.
Phase of Trial: Phase III
Latest Information Update: 14 Jun 2016
At a glance
- Drugs IC 51 (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- Acronyms JE-PIV
- Sponsors Intercell
- 29 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2008 New trial record.